Alarming TB cases in Austria
A third of the worlds population is infected with the bacterium Myobacterium tuberculosis which infects around nine million people annually.
Therapy
The Berlin TB Symposium
The WHO-Euro region ranges from Portugal to the East Asian parts of Russia, including Central Asia and the Southern Caucasus. Because of the increasing numbers of tuberculosis and rates of multidrug resistance (MDR TB), tuberculosis was declared a regional emergency in 2004.
Multiple-targeted therapies
The next big development in biological targeted therapies for advanced breast cancer will be drugs acting via multiple mechanisms, experts told delegates attending the 1st Asian Breast Cancer conference, held in New Delhi 9-10 February.
Radiation treatment decisions in patients with prostate cancer and suspected lymph node metastasis based on USPIO-MRI
Prostate cancer is the most frequent cancer in men with about 49,000 newly diagnosed cancers in Germany and 6,000 in the Netherlands, annually.
Improvement to therapeutic effects for seasonal rhinitis
Patients suffering from moderate to severe seasonal allergic rhinitis experience significantly improved therapeutic effects when combining nasal Azelastine spray with Fluticason nasal spray as opposed to using Fluticason nasal spray by itself. Those are the surprising results of a study released by the Annals of Allergy & Asthma Immunology (1) in January 2008. Azelastine is a first-line,…
Fibroid Embolisation: So Promising for Women, So Unavailable in Europe
Uterine fibroids are the most common form of benign pelvic tumor, with about 30-50% of women between the ages of 35-45 years reporting them. Although many women are asymptomatic, those who experience the symptoms of bladder pressure, frequent and very heavy menstrual periods, and uterine pain, have a reduced quality of life.
MR contrast agents: A step up from compartmental to targeted imaging
Andrea Martini and Joerg Larsen, of the Institute for Roentgendiagnostics, Braunschweig Teaching Hospitals, Germany, discuss nanotechnology, hybrid imaging and the quest for a personalised medicine.
A novel PET tracer for early detection of Alzheimers
Amyloidb (Ab) plaque formation is a hallmark of Alzheimers disease (AD) and precedes the onset of dementia. Australian researchers reported the first data on the validity in humans of a new PET tracer binding to Ab. Their data suggest that 18F-BAY94-9172 of Bayer Schering Pharma AG can reliably detect Ab deposition and thereby aid early diagnosis, differential diagnosis, and therapeutic…
Open High-field MRI
As part of a research and development project, doctors at the University Hospital Magdeburg, Germany, are treating oncology patients with local minimally invasive surgery (MIS) which, for the first time, can be carried out under radiological image control using high-field magnetic resonance imaging (MRI). The system offers excellent image quality under extremely favourable, radiation-free…
How to achieve tight glucose control
By Professor Jean-Charles Preiser MD PhD, of the Department of General Intensive Care, University Hospital Centre, University of Liege, Belgium
MR probes for molecular imaging
Molecular imaging aims at the in vivo quantitative visualisation of molecules and molecular events that occur at cellular level. The potential towards clinical translation is huge, because the same modalities used in medical imaging are used in molecular imaging investigations.
Helical tomotherapy
By Rudolf Schwarz and Andreas Krüll, of the Section of Radiation Oncology Department, Ambulanzzentrum GmbH of the University Medical Center Hamburg-Eppendorf
Mental health and radiology
The Uliazpi Foundation in Spain, which studies and cares for severely mentally retarded patients, carried out an interesting study to identify bone mineral density values in a group of its patients, compare these with the general population and investigate the possible influence on these values on certain clinical variables and therapeutic regimens.
The 23rd annual EAU Congress
The Milano Convention Centre (MIC) is the largest of its kind in Italy. Certainly that space will prove valuable this March, when 9,500 urologists from 100 countries attend the 23rd EAU Congress, the second biggest of its kind in the world. Apart from attending the congress and related trade fair, they may also glimpse Milan's many attractions: the cathedral, La Scala, Sforza's Castle, or even…
New Optical Breast Imaging System
Advanced Research Technologies Inc. ("ART") announced the first sale of SoftScan® optical breast imaging system to the Sunnybrook Health Sciences Centre ('Sunnybrook") in Toronto, Canada. Sunnybrook is the first health centre to purchase a SoftScan imaging system since the Canadian company received regulatory approval for commercialization in Europe and Canada for its optical breast imaging…
New system speeds-up UGI cancer diagnosis and treatment
The upper gastrointestinal (UGI) team at Milton Keynes Hospital NHS Foundation Trust has developed a rapid access service for upper gastrointestinal cancers. The new system means that patients are referred directly from their GP to the hospital for an endoscopy.
Computerised model of the heart to develop new therapies
During a workshop organized by the European Science Foundation (ESF), researchers discussed further steps in developing computerised “in-silico” models of the heart that simulate the real heart and enable possible drugs and therapies to be tested without risk to people.
COPD: New therapy reduces mortality
Patients with severe COPD may benefit more from therapy that combines salmeterol and fluticasone [SFC] than treatment with tiotropium, according to results from a long-term, multi-center study, “Investigating New Standards for Prophylaxis in Reducing Exacerbations” (INSPIRE) that directly compared the two therapies.
Neuroendocrine Cancer
The collaboration between two companies may pave the way for the development of new therapy options for neuroendocrine tumors: Covidien LTd, a global provider of healthcare products and BioSynthema Inc., a company specialized in the discovery and development of molecular targeted biophamaceuticals recently signed an agreement that will gain BioSynthema access to specific Covidien proprietary…
CLINICIP
Presented during a symposium at Langenbeck-Virchow-Haus, in Berlin, the European CLINICIP research project aims to develop a method to improve glycaemic control during intensive care and provide a low-risk monitoring and control system that can control the metabolism of the critically ill
The optical biopsy: Coming into view?
A British collaboration has secured £325,000 (?460,000) of government backing to develop an in vivo optical imaging probe for diagnostic and therapeutic applications in oncology. The long-term objective is to use optical coherence tomography (OCT), an interferometric imaging modality, to perform real-time diagnosis and to guide the removal of cancerous or precancerous tissue during the same…
A new scientific association promotes use in mainstream medicine
Enzymes are biocatalysts that control the different metabolic processes of living organisms. These range from digestion to the copying of genetic information.
Successful OCT imaging during cancer surgery
UK - Optical imaging company Michelson Diagnostics Ltd (MDL) has announced successful initial results from clinical testing of its novel optical coherence tomography (OCT) imaging technology. The tests, performed on cancerous and precancerous human oesophagus and lymph node tissue, were designed to establish the potential value of MDL's optical imaging technology used during cancer surgery.
E-psychiatry
The uses of the internet in psychiatry have increased in recent years, and there is evidence that professionals, patients, families, institutions and other agents benefit from it.
Nutrition and health
In Europe, more than ten million people suffer from diabetes mellitus, 90 percent of whom have diabetes type II.
